Huntington's disease (HD) is an autosomal neurodegenerative disease that is characterized
by an excessive number of CAG trinucleotide repeats within the huntingtin gene (HTT). HD …

Huntington disease (HD) is an autosomal dominant neurodegenerative disorder
characterized by motor, behavioral, and cognitive manifestations. It is caused by an …

Motor and phonic tics associated with Tourette syndrome (TS) can range in severity from
barely perceptible to disabling and most patients have a variety of behavioral co-morbidities …

Introduction Tourette syndrome (TS) is a childhood-onset neurobehavioral disorder
characterized by tics. Pharmacotherapy is advised for patients whose symptoms affect their …

Objective To evaluate the long-term safety and efficacy of deutetrabenazine in patients with
tardive dyskinesia (TD). Method Patients with TD who completed the 12 week, phase 3 …

Objectives The aim of this study was to review our “real-world” experience with the vesicular
monoamine transporter 2 (VMAT2) inhibitors tetrabenazine (TBZ), deutetrabenazine (DTBZ) …

Huntington's disease (HD) is an autosomal-dominant progressive neurodegenerative
disease that manifests with a triad of symptoms including motor dysfunctions, cognitive …

Background: Tardive Dyskinesia (TD) is a neurological disorder characterized by involuntary
movements, often caused by dopamine receptor antagonists. Vesicular Monoamine …

Introduction Chorea is a common motor manifestation of Huntington's disease (HD). Two
vesicular monoamine transporter type 2 (VMAT-2) inhibitors have been approved by the …

Background Tourette syndrome (TS) is a neurodevelopmental disorder characterized by
motor and phonic tics. Objective To assess the safety and efficacy of deutetrabenazine (Teva …